Hunt Valley, United States
Sterilex, a biotechnology company founded in 1994 and headquartered in the United States, is a recognized leader in developing antimicrobial, anti-biofilm, and decontamination products for various industries including animal health, food processing, water care, industrial processing, and environmental remediation.
The company's patented platform technology, PerQuat® technology, is a unique alkaline peroxygen phase-transfer chemistry that can effectively penetrate and remove biofilms, kill microorganisms, and remove organic and chemical contaminants, including nerve agents, organophosphorus pesticides, and carbamates.
Sterilex received a Private Equity Round investment on 27 April 2021 from Paine Schwartz Partners.
With its innovative solutions for microbial control and a focus on multiple industries, Sterilex continues to be a promising player in the biotechnology, healthcare, and pharmaceutical sectors.
